Compare STRO & XRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | XRPN |
|---|---|---|
| Founded | 2003 | 2024 |
| Country | United States | United States |
| Employees | 131 | 2 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 324.7M |
| IPO Year | N/A | N/A |
| Metric | STRO | XRPN |
|---|---|---|
| Price | $34.99 | $10.35 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | ★ 223.8K | 93.7K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $72.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $10.10 |
| 52 Week High | $36.00 | $10.44 |
| Indicator | STRO | XRPN |
|---|---|---|
| Relative Strength Index (RSI) | 72.00 | 53.01 |
| Support Level | $0.78 | $10.31 |
| Resistance Level | N/A | $10.44 |
| Average True Range (ATR) | 2.61 | 0.03 |
| MACD | 0.25 | -0.00 |
| Stochastic Oscillator | 87.24 | 28.00 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Armada Acquisition Corp II is a blank check company.